Readoutin 45d
Tolmar Inc. — TOL2506
Phase 3 primary completion: Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer.
- Date
- Jan 2027
- Type
- Readout
- Indication
- Breast Cancer
Readoutin 45d
Phase 3 primary completion: Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.